RM

Robert McDowell

Genentech: 35 patents #52 of 2,392Top 3%
Hoechst Gmbh: 10 patents #371 of 4,020Top 10%
3B 3-V Biosciences: 8 patents #5 of 14Top 40%
MY Myokardia: 8 patents #2 of 24Top 9%
AS Aventis Pharma S.A.: 6 patents #63 of 591Top 15%
AG Aventis Pharma Deutschland Gmbh: 4 patents #84 of 418Top 25%
SP Sunesis Pharmaceuticals: 3 patents #53 of 122Top 45%
Stanford University: 3 patents #828 of 5,197Top 20%
HR Hoechst Marion Roussel: 2 patents #94 of 309Top 35%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
UT University Of Texas: 1 patents #37 of 278Top 15%
SA Sanofi-Aventis: 1 patents #630 of 1,008Top 65%
HG Hoechst Marion Roussel Deutschland Gmbh: 1 patents #7 of 62Top 15%
📍 San Francisco, CA: #275 of 26,999 inventorsTop 2%
🗺 California: #4,767 of 386,348 inventorsTop 2%
Overall (All Time): #31,841 of 4,157,543Top 1%
67
Patents All Time

Issued Patents All Time

Showing 51–67 of 67 patents

Patent #TitleCo-InventorsDate
6034216 Low molecular weight peptidomimetic growth hormone secretagogues Todd C. Somers, Kathleen Ann Elias, Ross G. Clark, Mark S. Stanley, John Burnier +1 more 2000-03-07
6011045 Vitronectin receptor antagonists, their preparation and their use Volkmar Wehner, Hans Ulrich Stilz, Anuschirwan Peyman, Jochen Knolle, Jean-Marie Ruxer +3 more 2000-01-04
6005117 Imino compounds, process for their preparation and their use as victronectin antagonists Volkmar Wehner, Jochen Knolle, Hans Ulrich Stilz, Jean-Francois Gourvest, Denis Carniato +3 more 1999-12-21
5990145 Vitronectin receptor antagonists, their preparation and their use Volkmar Wehner, Hans Ulrich Stilz, Anuschirwan Peyman, Karlheinz Scheunemann, Jean-Marie Ruxer +3 more 1999-11-23
5846932 Receptor specific atrial natriuretic peptides David G. Lowe, Brian C. Cunningham, David A. Oare, John Burnier 1998-12-08
5843941 Ras farnesyl transferase inhibitors James Marsters, Michael S. Brown, Craig Crowley, Joseph L. Goldstein, Guy L. James +4 more 1998-12-01
5798337 Low molecular weight peptidomimetic growth hormone secretagogues Todd C. Somers, Kathleen Ann Elias, Ross G. Clark, Mark S. Stanley, John Burnier +1 more 1998-08-25
5756452 Platelet aggregation inhibitors having high specificity for GP II.sub.b III.sub.a John Burnier, Thomas Gadek 1998-05-26
5674863 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Brent Blackburn, Peter L. Barker, Thomas Gadek, Lawrence R. McGee, Todd C. Somers +2 more 1997-10-07
5674865 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a Brent Blackburn, Peter L. Barker, Thomas Gadek, Lawrence R. McGee, Todd C. Somers +2 more 1997-10-07
5665704 Receptor specific atrial natriuretic peptides David G. Lowe, Brian C. Cunningham, David A. Oare, John Burnier 1997-09-09
5663166 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Brent Blackburn, Peter L. Barker, Thomas Gadek, Lawrence R. McGee, Todd C. Somers +2 more 1997-09-02
5565449 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Brent Blackburn, Peter L. Barker, Thomas Gadek, Lawrence R. McGee, Todd C. Somers +2 more 1996-10-15
5532359 Ras farnesyl transferase inhibitors James Marsters, Michael S. Brown, Craig Crowley, Joseph L. Goldstein, Guy L. James +4 more 1996-07-02
5493007 Platelet aggregation inhibitors having high specificity for GPIIBIIIA John Burnier, Thomas Gadek 1996-02-20
5403836 Benzazepine platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub.a receptor Brent Blackburn, Thomas Gadek, Rob Webb 1995-04-04
5250679 Nonpeptidyl platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub. receptor Brent Blackburn, Thomas Gadek, Peter L. Barker, Lawrence R. McGee, Rob Webb 1993-10-05